Briacell Therapeutics Corp. (NASDAQ:BCTX) (TSX-V:BCT) CEO Dr Bill Williams explains to Proactive how the Berkeley, California and Vancouver, Canada-based group has bounced back from its 'year on life support.' Williams says now the group is 'getting the trains running again' with its recent Nasdaq listing and $25M raise, expected to be spent on its breast cancer focused clinical trials.
BriaCell Therapeutics 'getting the trains running again' with Nasdaq listing and $25M raise
